Becton Dickinson stock heads into the open after a 2.1 percent gain
Published on 09/15/2026 at 08:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Becton Dickinson stock closed at USD 181.59 on the NYSE on September 14, 2026, gaining 2.1 percent from the previous close in a weak broader market. The shares moved between USD 177.75 and USD 182.10 on the day with trading volume close to recent averages, while the S&P 500 index fell 0.5 percent to 7,619.98.
September 14, 2026 in numbers
Becton, Dickinson and Company Inc. (ISIN US0718131099, NYSE: BDX) finished the last session at USD 181.59 compared with a prior close of USD 177.85, marking a 2.1 percent rise on September 14, 2026. According to NYSE quote data presented by finance portals, the stock's intraday range spanned an approximate low of USD 177.75 and a high near USD 182.10, placing the closing price toward the upper end of the day's trading band. Per aggregated market data over the past year, this level keeps the shares within their 52-week trading corridor and indicates that the latest move did not challenge either the 12-month high or low. While Becton Dickinson advanced, the S&P 500 index declined 0.5 percent to 7,619.98 on September 14, 2026, underscoring that the stock outperformed the broader US equity benchmark during the session.
In corporate news, BD highlighted an expansion of its intelligent robotics offering for pharmacy operations. As BD reported on September 14, 2026, Fairview Health Services became the first health system in the United States to deploy the BD Vmax 160, a next generation pharmacy automation robot aimed at managing complex specialty and refrigerated medicines in high-volume outpatient pharmacy operations. The announcement underlined BD's focus on automation and workflow efficiency in medication management, adding a company-specific angle to Monday's trading backdrop even as overall US stock indexes lost ground.
Today’s drivers and events
Today, September 15, 2026, Becton Dickinson enters the new session without a scheduled earnings release or annual meeting within the immediate five-day window in publicly referenced calendars, leaving recent strategic updates and broader market trends as potential influences on trading. The robotics announcement for the BD Vmax 160, detailed by BD, may continue to frame investor discussions around the company's automation capabilities and its role in supporting health systems that handle complex specialty therapies. At the same time, broader US equity sentiment after the S&P 500's 0.5 percent decline on September 14, 2026, as summarized by market wraps such as those from Barchart, provides the macro context heading into today's open.
